Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Catalyst Pharmaceuticals (CPRX) Return on Invested Capital (2019 - 2025)

Catalyst Pharmaceuticals' Return on Invested Capital history spans 7 years, with the latest figure at 0.05% for Q4 2025.

  • For Q4 2025, Return on Invested Capital fell 15.0% year-over-year to 0.05%; the TTM value through Dec 2025 reached 0.05%, down 15.0%, while the annual FY2025 figure was 0.05%, 20.0% down from the prior year.
  • Return on Invested Capital reached 0.05% in Q4 2025 per CPRX's latest filing, down from 0.21% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 0.41% in Q1 2021 to a low of 0.05% in Q4 2025.
  • Average Return on Invested Capital over 5 years is 0.23%, with a median of 0.21% recorded in 2021.
  • Peak YoY movement for Return on Invested Capital: plummeted -31bps in 2021, then increased 15bps in 2022.
  • A 5-year view of Return on Invested Capital shows it stood at 0.19% in 2021, then skyrocketed by 78bps to 0.34% in 2022, then plummeted by -61bps to 0.13% in 2023, then soared by 50bps to 0.2% in 2024, then plummeted by -76bps to 0.05% in 2025.
  • Per Business Quant, the three most recent readings for CPRX's Return on Invested Capital are 0.05% (Q4 2025), 0.21% (Q3 2025), and 0.22% (Q2 2025).